Financial statements Neurosys
Balance sheet data of NEUROSYS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 188 389,91 | 2 443 973,40 | 3 392 152,31 | 4 179 641,51 | 4 970 677,27 | 6 125 090,75 |
| A. Fixed assets | 73 912,50 | 116 612,90 | 230 612,50 | 305 975,28 | 351 608,54 | 845 332,42 |
| B. Current assets | 2 113 795,41 | 2 327 360,50 | 3 161 539,81 | 3 873 666,23 | 4 619 068,73 | 5 279 758,33 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 188 389,91 | 2 443 973,40 | 3 392 152,31 | 4 179 641,51 | 4 970 677,27 | 6 125 090,75 |
| A. Equity | 452 756,64 | 1 057 622,47 | 1 656 719,91 | 2 322 639,59 | 2 884 811,20 | 3 526 655,59 |
| B. Liabilities and provisions for liabilities | 1 735 633,27 | 1 386 350,93 | 1 735 432,40 | 1 857 001,92 | 2 085 866,07 | 2 598 435,16 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 624 424,90 | 1 386 350,93 | 1 735 432,40 | 1 857 001,92 | 2 085 866,07 | 2 598 435,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.